Detalhe da pesquisa
1.
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2.
Br J Cancer
; 128(12): 2283-2294, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076566
2.
Transcriptome-wide association study of breast cancer risk by estrogen-receptor status.
Genet Epidemiol
; 44(5): 442-468, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32115800
3.
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Genet Med
; 23(9): 1726-1737, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34113011
4.
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Hum Mutat
; 39(5): 593-620, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29446198
5.
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.
Breast Cancer Res Treat
; 161(1): 117-134, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796716
6.
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Breast Cancer Res
; 18(1): 64, 2016 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27459855
7.
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.
Br J Cancer
; 115(7): 776-83, 2016 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27537391
8.
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk.
PLoS Genet
; 9(3): e1003173, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23544012
9.
A Breast Cancer Candidate Locus at 6q Narrowed to 6q15-q21.
Genes (Basel)
; 15(2)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38397208
10.
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk.
medRxiv
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38496424
11.
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.
PLoS Genet
; 6(10): e1001183, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21060860
12.
High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer.
Genes (Basel)
; 14(8)2023 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37628611
13.
Characterisation of amplification patterns and target genes at chromosome 11q13 in CCND1-amplified sporadic and familial breast tumours.
Breast Cancer Res Treat
; 133(2): 583-94, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22002566
14.
The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 132(3): 1119-26, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212556
15.
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers.
Breast Cancer Res Treat
; 136(1): 295-302, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23011509
16.
The risk allele of SNP rs3803662 and the mRNA level of its closest genes TOX3 and LOC643714 predict adverse outcome for breast cancer patients.
BMC Cancer
; 12: 621, 2012 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-23270421
17.
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores.
J Natl Cancer Inst
; 114(1): 109-122, 2022 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320204
18.
Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.
PLoS One
; 16(11): e0260327, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34797887
19.
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Breast Cancer Res
; 12(3): R25, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20459607
20.
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.
Breast Cancer Res
; 12(4): R50, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20637093